SCHEMBL357654

SCHEMBL357654

[CH2]CCc1c[nH]cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL181706 0.86
SCHEMBL7497994 0.85
SCHEMBL2095403 0.83
SCHEMBL25316643 0.83
SCHEMBL25317673 0.83
SCHEMBL25317586 0.83
SCHEMBL25316852 0.83
SCHEMBL181427 0.80
SCHEMBL5322896 0.80 HRH4 (0.32)
Histamine SCHEMBL16163139 0.77 HRH4 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023023513-A9 STABILIZATION OF OLIGONUCLEOTIDE AND OLIGONUCLEOTIDE-PROTEIN COMPLEX USING ALKYLATED PHOSPHATE UNIVERSITY OF MASSACHUSETTS (US) 2023-06-01 WO claimed
WO-2023023513-A1 STABILIZATION OF OLIGONUCLEOTIDE AND OLIGONUCLEOTIDE-PROTEIN COMPLEX USING ALKYLATED PHOSPHATE UNIVERSITY OF MASSACHUSETTS (US) 2023-02-23 WO claimed
EP-1294699-B1 MODULATORS OF TNF- ALPHA SIGNALLING GENZYME CORP (US) 2016-04-13 EP claimed
US-8518999-B2 Modulators of TNF-αsignaling GENZYME CORPORATION (US) 2013-08-27 US claimed
US-20090326017-A1 PAIN-RELIEVING COMPOSITIONS AND USES THEREFOR THE UNIVERSITY OF QUEENSLAND (AU) 2009-12-31 US claimed
EP-0760811-B1 IMIDAZOLE DERIVATIVES AS HISTAMINE RECEPTOR H3 MODULATORS INST NAT SANTE RECH MED (FR) 2009-11-18 EP claimed
WO-2008080194-A1 PAIN-RELIEVING COMPOSITIONS AND USES THEREFOR THE UNIVERSITY OF QUEENSLAND (AU) 2008-07-10 WO claimed
US-6969728-B2 Antiinflammatory agents GENZYME CORPORATION (US) 2005-11-29 US claimed
EP-1567138-A1 USE OF DIAMIDE DERIVATIVES FOR INHIBITING CHRONIC TISSUE TRANSPLANT REJECTION Genzyme Corporation (US) 2005-08-31 EP claimed
US-20040163654-A1 Inhibition of chronic tissue transplant rejection GENZYME CORPORATION 2004-08-26 US claimed
WO-2004047825-A1 USE OF DIAMIDE DERIVATIVES FOR INHIBITING CHRONIC TISSUE TRANSPLANT REJECTION GENZYME CORPORATION (US) 2004-06-10 WO claimed
EP-1294699-A2 MODULATORS OF TNF- ALPHA SIGNALLING GENZYME CORPORATION (US) 2003-03-26 EP claimed
US-20020119988-A1 Antiinflammatory agents GENZYME CORPORATION 2002-08-29 US claimed
WO-2001087849-A2 MODULATORS OF TNF- ALPHA SIGNALING GENZYME CORPORATION (US) 2001-11-22 WO claimed
US-RE37303-E1 Imidazole compounds and their therapeutic applications INSTITUT NATIONAL DEL LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 2001-07-31 US claimed
US-6248765-B1 ANTIINFLAMMATORY AGENTS; HYPOTENSIVE AGENTS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICAL (FR) 2001-06-19 US claimed
US-5708171-A HISTAMINE H3-RECEPTOR ANTAGONIST INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 1998-01-13 US claimed
EP-0760811-A1 IMIDAZOLE DERIVATIVES AS HISTAMINE RECEPTOR H 3? (ANT)AGONISTS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 1997-03-12 EP claimed
WO-1996029315-A2 IMIDAZOLE DERIVATIVES AS HISTAMINE RECEPTOR H3 (ANT)AGONISTS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 1996-09-26 WO claimed
EP-0371467-A2 Beta-amino boron acid derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1990-06-06 EP claimed